Immuno-Biological Laboratories Co., Ltd. Logo

Immuno-Biological Laboratories Co., Ltd.

Develops and supplies immunological reagents and diagnostics for research and drug discovery.

4570 | T

Overview

Corporate Details

ISIN(s):
JP3921300004
LEI:
Country:
Japan
Address:
藤岡市中字東田1091番地1
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Immuno-Biological Laboratories Co., Ltd. (IBL) is a research-driven company that develops, manufactures, and supplies immunological research reagents and diagnostics. The company's portfolio includes ELISA kits, specialized antibodies, and cell culture-related products. IBL focuses on key therapeutic areas such as aging, neurodegenerative disorders, kidney diseases, inflammatory diseases, and glucose/lipid metabolism. A notable offering is the LipoSEARCH® lipoprotein analyzing system, which utilizes patented Gel Permeation High-Performance Liquid Chromatography (GP-HPLC) technology. The company collaborates with pharmaceutical partners and research institutions to support drug discovery and the development of novel diagnostics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 01:09
Report Publication Announcement
確認書
Japanese 8.7 KB
2025-11-14 01:07
Interim Report
半期報告書-第44期(2025/04/01-2026/03/31)
Japanese 173.9 KB
2025-06-27 06:30
Post-Annual General Meeting Information
臨時報告書
Japanese 23.0 KB
2025-06-27 02:05
Governance Information
内部統制報告書-第43期(2024/04/01-2025/03/31)
Japanese 25.4 KB
2025-06-27 02:04
Registration Form
確認書
Japanese 8.7 KB
2025-06-27 02:02
Annual Report
有価証券報告書-第43期(2024/04/01-2025/03/31)
Japanese 1.2 MB
2024-11-14 01:04
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-11-14 01:02
Interim Report
半期報告書-第43期(2024/04/01-2025/03/31)
Japanese 180.6 KB
2024-06-26 03:44
Post-Annual General Meeting Information
臨時報告書
Japanese 23.0 KB
2024-06-26 03:41
Governance Information
内部統制報告書-第42期(2023/04/01-2024/03/31)
Japanese 23.7 KB
2024-06-26 03:40
Registration Form
確認書
Japanese 8.7 KB
2024-06-26 03:38
Registration Form
有価証券報告書-第42期(2023/04/01-2024/03/31)
Japanese 1.2 MB
2024-02-14 01:10
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-02-14 01:07
Quarterly Report
四半期報告書-第42期第3四半期(2023/10/01-2023/12/31)
Japanese 161.4 KB
2023-11-14 01:02
Report Publication Announcement
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all Immuno-Biological Laboratories Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Immuno-Biological Laboratories Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Immuno-Biological Laboratories Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ANAVEX LIFE SCIENCES CORP. Logo
Developing precision therapeutics for neurodegenerative and CNS disorders.
United States of America
AVXL
Anbio Biotechnology Logo
Develops and supplies in vitro diagnostic solutions for human and veterinary markets.
United States of America
NNNN
Anebulo Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing an antidote for acute cannabinoid intoxication in ER patients.
United States of America
ANEB
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan
4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom
ANCR
ANI PHARMACEUTICALS INC Logo
Develops, manufactures, and markets branded/generic drugs and OTCs for niche therapeutic areas.
United States of America
ANIP
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden
ANNX
Annexon, Inc. Logo
Developing C1q inhibitors for autoimmune, neurodegenerative, and ophthalmic diseases.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea
065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania
ATB

Talk to a Data Expert

Have a question? We'll get back to you promptly.